[The effect of growth hormone therapy on thyroid parameters].

Q4 Medicine Cesko-Slovenska Pediatrie Pub Date : 1994-01-01
J Lebl, M Pechová, S Kolousková, M Snajderová
{"title":"[The effect of growth hormone therapy on thyroid parameters].","authors":"J Lebl,&nbsp;M Pechová,&nbsp;S Kolousková,&nbsp;M Snajderová","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Clinical observations and experimental studies indicate that administration of growth hormone (GH) affects thyroid parameters either via inhibited TSH secretion or via activation of the peripheral conversion of T4 to T3. For a period of six months after the onset of GH treatment basic thyroid parameters (TSH and total T3 and T4) were followed up in two groups of children: in 10 euthyroid girls with Turner's syndrome (TS) (age 6.2-11.3 years), hitherto not treated with GH and in six children (2 boys) with isolated idiopathic growth hormone deficiency (IGHD) (age 9.5-14.1 years). In the latter group GH treatment, 0.37 to 0.47 IU/kg/week for a period of 0.8 to 4.3 years preceded. This treatment was discontinued for 30 days before the investigation was started. During this treatment the condition was assessed as euthyroid without administration of L-thyroxine. Both groups of children were treated with GH administered by daily injection, girls with TS had a dose of 1 IU/kg/week, children with IGHD 0.42 IU/kg/week. In these girls with TS in the course of six months no change of the investigated parameters was recorded. In children with IGHD after three months' treatment a drop of T4 from (mean +/- SD) of 119 +/- 11 to 84 +/- 21 nmol/l (p = 0.01) occurred and a rise of the T3/T4 (x 100) index from 1.77 +/- 0.24 to 2.73 +/- 0.69 (p = 0.01) and of TSH from 1.1 +/- 0.7 to 2.2 +/- 0.6 mU/l (p = 0.005). The T3 level did not change. Within 6 months of treatment these changes receded completely and the levels returned to baseline values.(ABSTRACT TRUNCATED AT 250 WORDS)</p>","PeriodicalId":39741,"journal":{"name":"Cesko-Slovenska Pediatrie","volume":"49 1","pages":"34-7"},"PeriodicalIF":0.0000,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cesko-Slovenska Pediatrie","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Clinical observations and experimental studies indicate that administration of growth hormone (GH) affects thyroid parameters either via inhibited TSH secretion or via activation of the peripheral conversion of T4 to T3. For a period of six months after the onset of GH treatment basic thyroid parameters (TSH and total T3 and T4) were followed up in two groups of children: in 10 euthyroid girls with Turner's syndrome (TS) (age 6.2-11.3 years), hitherto not treated with GH and in six children (2 boys) with isolated idiopathic growth hormone deficiency (IGHD) (age 9.5-14.1 years). In the latter group GH treatment, 0.37 to 0.47 IU/kg/week for a period of 0.8 to 4.3 years preceded. This treatment was discontinued for 30 days before the investigation was started. During this treatment the condition was assessed as euthyroid without administration of L-thyroxine. Both groups of children were treated with GH administered by daily injection, girls with TS had a dose of 1 IU/kg/week, children with IGHD 0.42 IU/kg/week. In these girls with TS in the course of six months no change of the investigated parameters was recorded. In children with IGHD after three months' treatment a drop of T4 from (mean +/- SD) of 119 +/- 11 to 84 +/- 21 nmol/l (p = 0.01) occurred and a rise of the T3/T4 (x 100) index from 1.77 +/- 0.24 to 2.73 +/- 0.69 (p = 0.01) and of TSH from 1.1 +/- 0.7 to 2.2 +/- 0.6 mU/l (p = 0.005). The T3 level did not change. Within 6 months of treatment these changes receded completely and the levels returned to baseline values.(ABSTRACT TRUNCATED AT 250 WORDS)

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
生长激素治疗对甲状腺参数的影响。
临床观察和实验研究表明,生长激素(GH)通过抑制TSH分泌或激活外周T4到T3的转化来影响甲状腺参数。在GH治疗开始6个月后,对两组儿童的基本甲状腺参数(TSH和总T3和T4)进行了随访:10名患有特纳综合征(TS)的甲状腺功能正常的女孩(年龄6.2-11.3岁),迄今未接受GH治疗;6名患有孤立的特发性生长激素缺乏症(IGHD)的儿童(2名男孩)(年龄9.5-14.1岁)。在后一组GH治疗中,0.37至0.47 IU/kg/周,持续0.8至4.3年。在开始调查前停用该治疗30天。在此治疗期间,病情评估为甲状腺功能正常,无需给予l -甲状腺素。两组儿童均每日注射生长激素,TS组女孩剂量为1 IU/kg/周,IGHD组儿童剂量为0.42 IU/kg/周。在这些患有TS的女孩中,在六个月的过程中没有记录调查参数的变化。治疗3个月后,IGHD患儿T4从(平均+/- SD) 119 +/- 11下降到84 +/- 21 nmol/l (p = 0.01), T3/T4 (x 100)指数从1.77 +/- 0.24上升到2.73 +/- 0.69 (p = 0.01), TSH从1.1 +/- 0.7上升到2.2 +/- 0.6 mU/l (p = 0.005)。T3水平没有变化。治疗6个月后,这些变化完全消退,水平恢复到基线值。(摘要删节250字)
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cesko-Slovenska Pediatrie
Cesko-Slovenska Pediatrie Medicine-Pediatrics, Perinatology and Child Health
CiteScore
0.30
自引率
0.00%
发文量
32
期刊介绍: So stúpajúcou prevalenciou exogénnej obezity v detskom veku je pozorovaný i čoraz častejší výskyt zmien v lipidovom a sacharidovom metabolizme. Ich mediátorom je inzulínová reziste...
期刊最新文献
Prevention in paediatrics New therapies in cystic fibrosis Heart murmur in children The effect of restrictions associated with the covid-19 disease on the prevalence of overweight and obesity in Czech children Cystic fibrosis-related diabetes
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1